| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
128,799 |
43,057 |
$5.97M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
128,788 |
43,049 |
$1.50M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
283 |
268 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
125,566 |
40,318 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
20 |
19 |
$579.32 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,528 |
2,957 |
$261.38 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
26 |
26 |
$33.07 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$3.75 |